![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1419003
À¯·´ÀÇ À¶ÇÕ À¯ÀüÀÚ °Ë»ç ½ÃÀå : ºÐ¼® ¹× ¿¹Ãø(2023-2033³â)Europe Gene Fusion Testing Market: Analysis and Forecast, 2023-2033 |
À¯·´ÀÇ À¶ÇÕ À¯ÀüÀÚ °Ë»ç ½ÃÀå ±Ô¸ð´Â 2023³â 7,140¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç 2033³â¿¡´Â 2¾ï 4,820¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2023³âºÎÅÍ 2033³â±îÁö 13.27%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
À¶ÇÕ À¯ÀüÀÚ °Ë»ç ½ÃÀåÀº Ç¥Àû Ä¡·áÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ À¶ÇÕ À¯ÀüÀÚ °Ë»çÀÇ »ç¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÁÖ¿ä ½ÃÀå Åë°è | |
---|---|
¿¹Ãø ±â°£ | 2023³â-2033³â |
2023³â Æò°¡ | 7,140¸¸ ´Þ·¯ |
2033³â Àü¸Á | 2¾ï 4,820¸¸ ´Þ·¯ |
CAGR | 13.27% |
À¯·´ÀÇ À¶ÇÕ À¯ÀüÀÚ °Ë»ç ½ÃÀåÀº °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀå°ú ÁøÈ¸¦ °ÅµìÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â À¯·´ÀÌ Á¤¹ÐÀÇ·á¿Í Ç¥ÀûÄ¡·áÁ¦ °³¹ß¿¡ Á¡Á¡ ´õ ¸¹Àº ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖ´Â µî ¿©·¯ ¿äÀÎÀÌ ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. À¶ÇÕ À¯ÀüÀÚ °Ë»ç´Â ƯÁ¤ Áúº´À» À¯¹ßÇÏ´Â À¯ÀüÀÚ º¯À̸¦ ã¾Æ³»¾î ȯÀÚ °³°³Àο¡°Ô ¸ÂÃãÈµÈ Ä¡·á¸¦ Á¦°øÇϴµ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. À¯·´ÀÇ ÇコÄɾî Çõ½Å°ú ¿¬±¸¿¡ ´ëÇÑ Çå½ÅÀº À¶ÇÕ À¯ÀüÀÚ °Ë»ç ±â¼úÀÇ Áøº¸¸¦ ÃËÁøÇϰí, ´õ ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖ°í ´õ Á¤È®ÇÏ°Ô ¸¸µé°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ Áö¿ªÀÇ °·ÂÇÑ Á¦¾à ¹× »ý¸í°øÇÐ ºÎ¹®Àº »õ·Î¿î Ä¡·áÁ¦¸¦ °³¹ßÇϱâ À§ÇØ ÀÌ·¯ÇÑ °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
¶ÇÇÑ, ±ÔÁ¦ ´ç±¹ÀÇ Áö¿ø°ú ¿¬±¸±â°ü°ú ¾÷°è °ü°èÀÚµéÀÇ Çù·Â °ü°èµµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. À¯·´¿¡¼ °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿Í ºÐÀÚÁø´Ü¿¡ ´ëÇÑ °ü½ÉÀÌ Áö¼ÓµÇ°í ÀÖ´Â ¸¸Å, ÀÌ Áö¿ªÀÇ À¶ÇÕ À¯ÀüÀÚ °Ë»ç ½ÃÀåÀº Áö¼ÓÀûÀÎ ¼ºÀå°ú Çõ½ÅÀÌ ¿¹»óµË´Ï´Ù.
ÀÌ º¸°í¼´Â À¯·´ÀÇ À¶ÇÕ À¯ÀüÀÚ °Ë»ç ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä¿Í ÇÔ²² ÀûÀÀÁõº°, ±¹°¡º° µ¿Çâ, ½ÃÀå ÁøÃâ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.
“The Europe Gene Fusion Testing Market Expected to Reach $248.2 Million by 2033.”
The Europe gene fusion testing market was valued at $71.4 million in 2023 and is anticipated to reach $248.2 million by 2033, witnessing a CAGR of 13.27% during the forecast period 2023-2033. The gene fusion testing market is anticipated to experience growth due to the increasing use of gene fusion testing for the advancement of targeted therapies.
KEY MARKET STATISTICS | |
---|---|
Forecast Period | 2023 - 2033 |
2023 Evaluation | $71.4 Million |
2033 Forecast | $248.2 Million |
CAGR | 13.27% |
The gene fusion testing market in Europe is experiencing significant growth and evolution. This can be attributed to several factors, including the region's increasing focus on precision medicine and the development of targeted therapies. Gene fusion testing, which involves identifying genetic alterations that drive certain diseases, plays a pivotal role in tailoring treatments to individual patients. Europe's commitment to healthcare innovation and research is fostering advancements in gene fusion testing technologies, making them more accessible and accurate. Additionally, the region's strong pharmaceutical and biotechnology sectors are driving demand for these tests as they seek to develop novel therapeutics.
Furthermore, regulatory support and collaborations between research institutions and industry players are contributing to market expansion. As Europe continues to emphasize personalized medicine and molecular diagnostics, the gene fusion testing market in the region is poised for continued growth and innovation.
Workflow/Innovation Strategy: The Europe gene fusion testing market (by indication) has been segmented into solid tumors and hematological malignancies. Moreover, the study provides the reader with a detailed understanding of the different indication of gene fusion testing in solid tumors.
Growth/Marketing Strategy: Gene fusion testing is a molecular diagnostic method employed to identify and analyze distinct genetic alterations in cancer cells. It arises when two distinct genes, typically from different chromosomes, abnormally join together, giving rise to a hybrid gene that generates a unique protein with modified functions.
Competitive Strategy: Key players in the Europe gene fusion testing market have been analyzed and profiled in the study, including manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the Europe gene fusion testing market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and regional presence.
|
|